Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy

Sigmund AM, Sahasrabudhe KD, Bhatnagar B

Blood and Lymphatic Cancer: Targets and Therapy 2020, 10:7-20

Published Date: 3 November 2020